RedHill Biopharma Announces Exercise of Stock Options by Directors and Senior Management
TEL-AVIV, Israel, Jan. 9 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced the exercise, in the last week, of stock options to purchase [...]